Terms ending in 2026
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,425,631 | Compounds and Methods of Use In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,562,017 | Novel Hydrogen Sulfate Salt In force · High confidence | Alexion Pharma International Operations Limited | In force | High confidence |
2 of 2 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.